521 related articles for article (PubMed ID: 19738121)
21. Need for inferior vena cava filters in cancer patients: a surrogate marker for poor outcome.
Barginear MF; Lesser M; Akerman ML; Strakhan M; Shapira I; Bradley T; Budman DR
Clin Appl Thromb Hemost; 2009; 15(3):263-9. PubMed ID: 18385149
[TBL] [Abstract][Full Text] [Related]
22. Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents.
Pruemer J
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S26-39; quiz S41-2. PubMed ID: 16638458
[TBL] [Abstract][Full Text] [Related]
23. Managing cancer-related venous thromboembolic disease: low-molecular-weight heparins and beyond.
O'Connell CL; Liebman HA
Expert Rev Hematol; 2008 Dec; 1(2):175-82. PubMed ID: 21082922
[TBL] [Abstract][Full Text] [Related]
24. Venous thromboembolism in patients with cancer: an overview for pharmacists using a case-based approach.
Pangilinan JM
J Pharm Pract; 2010 Aug; 23(4):294-302. PubMed ID: 21507829
[TBL] [Abstract][Full Text] [Related]
25. [Prevention and treatment of venous thromboembolism in patients with cancer].
Struve S; Wendtner CM
Dtsch Med Wochenschr; 2012 Oct; 137(40):2007-9. PubMed ID: 22987155
[No Abstract] [Full Text] [Related]
26. Cancer-associated thrombosis: focus on extended therapy with dalteparin.
Bick RL
J Support Oncol; 2006 Mar; 4(3):115-20. PubMed ID: 16553136
[TBL] [Abstract][Full Text] [Related]
27. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
28. Dose escalation of low molecular weight heparin in patients with recurrent cancer-associated thrombosis.
Ihaddadene R; Le Gal G; Delluc A; Carrier M
Thromb Res; 2014 Jul; 134(1):93-5. PubMed ID: 24835673
[TBL] [Abstract][Full Text] [Related]
29. Recurrent thromboembolism in cancer patients: incidence and risk factors.
Prandoni P; Piccioli A; Pagnan A
Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():3-8. PubMed ID: 14730471
[TBL] [Abstract][Full Text] [Related]
30. Thrombocytopenia and other hot topics.
DeLoughery TG
Am J Clin Oncol; 2009 Aug; 32(4 Suppl):S13-7. PubMed ID: 19654480
[TBL] [Abstract][Full Text] [Related]
31. [Cancer, thromboembolia and antithrombotic therapy: is there an anticoagulant of choice?].
Scharf RE
Dtsch Med Wochenschr; 2011 Nov; 136(47):2403. PubMed ID: 22094968
[No Abstract] [Full Text] [Related]
32. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
33. Impact of venous thromboembolism and anticoagulation on cancer and cancer survival.
Kuderer NM; Ortel TL; Francis CW
J Clin Oncol; 2009 Oct; 27(29):4902-11. PubMed ID: 19738120
[TBL] [Abstract][Full Text] [Related]
34. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
Merli GJ
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
[TBL] [Abstract][Full Text] [Related]
35. Management of thrombosis in the cancer patient.
Andrea N; Ansell J
J Support Oncol; 2003; 1(4):235-8, 240-2; discussion 239-40, 243-5. PubMed ID: 15334865
[TBL] [Abstract][Full Text] [Related]
36. Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism.
Parpia S; Julian JA; Thabane L; Lee AY; Rickles FR; Levine MN
Contemp Clin Trials; 2011 Nov; 32(6):829-33. PubMed ID: 21777700
[TBL] [Abstract][Full Text] [Related]
37. Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?
Caine GJ; Lip GY
Arch Intern Med; 2003 May; 163(10):1243-4; author reply 1244. PubMed ID: 12767973
[No Abstract] [Full Text] [Related]
38. Venous thromboembolism in cancer patients undergoing major surgery.
Osborne NH; Wakefield TW; Henke PK
Ann Surg Oncol; 2008 Dec; 15(12):3567-78. PubMed ID: 18841419
[TBL] [Abstract][Full Text] [Related]
39. Clinical studies with anticoagulants to improve survival in cancer patients.
Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
[TBL] [Abstract][Full Text] [Related]
40. Thromboprophylaxis during chemotherapy after advanced cancer.
Agnelli G; Verso M
Thromb Res; 2007; 120 Suppl 2():S128-32. PubMed ID: 18023706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
